-
Adipose ANGPTL4 Controls Triglyceride Partitioning
2026-09-09
This mouse study separates the adipocyte-specific actions of ANGPTL4 from systemic ANGPTL4 deficiency and shows that its metabolic effects depend strongly on diet duration. Adipocyte ANGPTL4 loss increased adipose LPL activity and triglyceride uptake under baseline conditions, but chronic high-fat feeding uncoupled higher LPL activity from enhanced triglyceride delivery and largely eliminated early improvements in glucose homeostasis.
-
EdU Cell Proliferation Kit: From Signal to Mechanism
2026-09-08
The EdU Cell Proliferation Kit converts DNA synthesis into a quantitative TMB signal for rigorous cell cycle S-phase detection. This guide shows how to use that readout as an orthogonal validation layer for ARL4C-driven rheumatoid arthritis research, drug response, and genotoxicity studies.
-
Halazone Workflows for Water and Neurophysiology
2026-09-08
Halazone supports two contrasting laboratory use cases: rapid oxidative water disinfection and mechanistic sodium-current experiments. This guide translates product data and frog-nerve electrophysiology into practical assay workflows, controls, and troubleshooting decisions.
-
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus
2026-09-07
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based detection. It is suited to research workflows such as in situ hybridization and Northern blot hybridization, but it is not intended for diagnostic, therapeutic, or medical use.
-
Phenothiazines, ROS, and Macrophage Antibacterial Defense
2026-09-05
The reference study identifies phenothiazines as host-directed antibacterial leads that strengthen macrophage control of intracellular bacteria through reactive oxygen species (ROS), lysosomal activity, and autophagy. Its inhibitor and in vivo experiments connect these cellular mechanisms with reduced Salmonella-associated tissue injury, while also defining important limits for translating a dopamine-active phenothiazine into infection research.
-
Phenothiazines, ROS, and Macrophage Defense
2026-09-05
Qiu et al. show that phenothiazines strengthen macrophage control of intracellular bacteria through coordinated lysosomal activity, autophagy, and reactive oxygen species accumulation. The findings position perphenazine as a host-directed antibacterial lead while clarifying that its immune effects require mechanistic validation beyond its established neuropharmacology.
-
GDC-0994: From ERK Mechanism to Translation
2026-09-04
GDC-0994 is a potent, selective ERK1/2 inhibitor that offers translational researchers a way to connect MAP kinase pathway control with measurable tumor and liver phenotypes. This thought-leadership perspective integrates oncology evidence, a zebrafish cholestasis study, assay strategy, formulation considerations, and the limitations that should guide cross-domain interpretation.
-
Sulfo-NHS-LC-Biotin: Practical Protocol
2026-09-04
Sulfo-NHS-LC-Biotin provides water-compatible, irreversible biotin labeling of primary amines on proteins, peptides, and intact-cell surface proteins for downstream detection or capture. It is appropriate for extracellular labeling and streptavidin workflows, but not for reversible tagging or intracellular labeling of intact cells.
-
Triacetin: From Mechanism to Translational Strategy
2026-09-03
Triacetin, or glyceryl triacetate, is more than a formulation excipient: it is an experimental metabolic and epigenetic research reagent with applications spanning glioblastoma, lipid regulation, and ocular delivery. This article translates its mechanistic signals into practical study-design guidance while defining the evidence boundaries that matter for translational decision-making.
-
Aligned Silk Fibroin–Ce6 Films for Infected Wounds
2026-09-03
The reference study developed an aligned silk fibroin electrospun film functionalized with Chlorin e6 (Ce6) for light-activated treatment of Staphylococcus aureus-infected wounds. Its innovation is the integration of directional cell guidance, reactive oxygen species generation, rapid antibacterial photodynamic therapy, and later-stage macrophage modulation in one biomaterial platform.
-
Go 6983: PKC Inhibition in Metabolic Lineage Assays
2026-09-02
Go 6983 is a pan-PKC inhibitor for dissecting kinase-dependent phenotypes without confusing pathway effects with metabolic or lineage changes. This guide uses human blastoid research to develop more rigorous PKC signaling pathway research, cancer progression studies, and cell-based assay strategies.
-
Streptavidin-FITC for Mechanistic LNP Trafficking
2026-09-02
Streptavidin-FITC is more than a fluorescent detection reagent: when integrated with biotinylated nanoparticle and cell assays, it can help translational researchers distinguish particle localization from productive nucleic acid delivery. This article connects fluorescein-based biotin detection with emerging evidence that LNP surface charge and target-cell V-ATPase activity jointly shape intracellular trafficking.
-
Hoechst 33342/PI Double Staining Kit Guide
2026-09-01
The Hoechst 33342/PI Double Staining Kit (SKU K2237) provides a fluorescence-based way to distinguish nuclear chromatin changes from loss of plasma membrane integrity in cultured cells. It is intended for research workflows involving apoptosis and necrosis assessment, not for diagnostic, clinical, or medical use.
-
Perphenazine Workflows for Neuropharmacology Research
2026-08-31
Perphenazine is a dopamine D2 receptor antagonist that connects receptor pharmacology with mitochondrial, analgesic-tolerance, and host-directed antibacterial assays. This practical guide covers concentration design, macrophage ROS–autophagy experiments, controls, and troubleshooting for reproducible research use.
-
Neuromedin S (rat): GPCR Assay Guide
2026-08-31
Neuromedin S (rat), SKU B5466, provides a defined peptide input for controlled neuromedin U receptor signaling and GPCR/G protein signaling workflows. It supports research assay development and pathway studies, but no directly matched paper evidence is supplied for assay potency; it is not intended for diagnostic, therapeutic, or medical use.